- Global Pharma News & Resources

Global TNF Inhibitors Market 2019-2023: Increasing Prevalence of Autoimmune Disorders Driving Growth -

The "Global TNF Inhibitors Market 2019-2023" report has been added to's offering.

The Global TNF Inhibitors Market to grow at a CAGR of 9.58% during the period 2019-2023.

The report, TNF Inhibitors Market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the application of TNF inhibitors in healthcare across the globe.

According to the report, one driver influencing this market is the increasing prevalence of autoimmune disorders across the globe. The rising incidences of tumor necrosis factor cancer and growing prevalence of various autoimmune disorders such as RA, psoriasis, and Chron's disease is expected to fuel the demand for TNF immunology across the period of forecast.

One trend affecting this market is the growing number of strategic alliances. At the present, biotech companies dominate the research area for drugs for tumor necrosis factor as they out-license the molecules or technology platforms to the bigger pharmaceutical companies.

Further, the report states that one challenge affecting this market is the growing advent of biosimilars. Vendors are increasingly focused on the development of biosimilars, which is expected to hinder the growth of the TNF inhibitors market.

Key vendors

  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • UCB

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Market Landscape

Part 04: Market Sizing

Part 05: Five Forces Analysis

Part 06: Customer Landscape

Part 07: Geographic Landscape

Part 08: Market Segmentation By Indication

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Part 14: Appendix

For more information about this report visit

View source version on

Editor Details

Last Updated: 24-Oct-2018